Trial Profile
Effect of Slow-release Melatonin (Circadin) Therapy on Idiopathic REM Sleep Behavior Disorder: a Pilot Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications REM-sleep-behavior-disorder
- Focus Therapeutic Use
- 26 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 31 Dec 2017.
- 21 Jul 2016 New trial record